Genetics of Neurodegeneration
Neurodegeneration involves progressive loss of neuronal structure and function, driven by protein aggregation, neuroinflammation, mitochondrial dysfunction, and impaired clearance. Genetic variants influencing these mechanisms may affect neurodegeneration risk and post-COVID neurological outcomes.
This page is for educational and informational purposes only. Not a diagnostic tool. Always consult a qualified healthcare provider.
What is Neurodegeneration?
Neurodegenerative conditions include Alzheimer's disease (amyloid and tau pathology), Parkinson's disease (alpha-synuclein and LRRK2), and amyotrophic lateral sclerosis (TDP-43, SOD1, C9orf72). Shared mechanisms include mitochondrial dysfunction, oxidative stress, neuroinflammation (microglial activation), impaired autophagy, and protein clearance deficits. COVID-19 has been associated with accelerated neurodegeneration risk in epidemiological studies, and Long COVID patients show brain imaging changes and elevated neurodegeneration biomarkers (neurofilament light chain, p-tau). Genetic variants in APOE4 (Alzheimer's), LRRK2/SNCA (Parkinson's), and GBA (lysosomal function) may modulate neurological vulnerability after COVID-19.
Biological pathways commonly discussed in relation to Neurodegeneration
Research into Neurodegenerative Disease Risk and Neurological Decline has highlighted several biological pathways that may be relevant. Genetic variants within these pathways may influence individual susceptibility, symptom severity, or the trajectory of the condition.
Protein Aggregation
Neurodegenerative diseases are characterised by misfolded protein aggregates: amyloid-beta and tau (AD), alpha-synuclein (PD), TDP-43 (ALS/FTLD), and huntingtin (HD). APOE4 impairs amyloid clearance. LRRK2 and GBA variants promote alpha-synuclein aggregation. Genetic variants affecting chaperone and proteasome function modulate aggregation risk.
Neuroinflammation Neuro
Microglial activation is central to neurodegeneration. TREM2 variants (particularly R47H) reduce microglial amyloid phagocytosis capacity, increasing AD risk. CR1 and CLU (clusterin) variants affect complement-mediated synaptic pruning. COVID-19 triggers neuroinflammation that may accelerate pre-existing pathology.
Autophagy Lysosome
Autophagy and lysosomal pathways clear damaged proteins and organelles. GBA (glucocerebrosidase) mutations — the strongest common genetic risk factor for Parkinson's disease — impair lysosomal function and promote alpha-synuclein accumulation. BECN1 and ATG variants affect autophagic flux.
Mitochondrial Neuro
Neuronal mitochondrial function is critical given high neuronal energy demands. PINK1 and PARKIN (PARK2) mutations cause mitochondrial dysfunction in Parkinson's disease by impairing mitophagy. SIRT1 and PGC-1alpha (PPARGC1A) regulate neuronal mitochondrial biogenesis and stress responses.
Key genes studied in relation to Neurodegeneration
The following genes have been studied in relation to Neurodegenerative Disease Risk and Neurological Decline. These genes span the biological pathways most commonly discussed in this area of research.
Genetic variants commonly discussed
The following genetic variants (SNPs) are found in genes that have been studied in relation to Neurodegeneration. Each variant represents a position in the genome where individuals may carry different alleles.
10 variants total across genes studied in relation to Neurodegeneration.
How personal DNA data may provide educational insights
Consumer DNA files from 23andMe, AncestryDNA, and MyHeritage contain raw SNP data. When you upload your file to ChronicDNA, the analysis engine checks your genotype against a curated panel of 80+ genes selected for their relevance to Long COVID, ME/CFS, and connected biological pathways - some of which may relate to areas such as Neurodegeneration.
This is not a diagnostic service. Genetic variants do not determine whether you have Neurodegeneration, nor do they predict your clinical outcomes. The report is educational - it explains which variants you carry, what the research says about them, and how they fit into the biological pathways most relevant to chronic illness. All results should be discussed with a qualified healthcare provider.
Related conditions and pathways
Neurodegeneration shares biological pathways and genetic associations with the following related conditions and areas of research.
Frequently asked questions
Does COVID-19 increase neurodegeneration risk?
Large epidemiological studies have documented elevated risk of new neurological diagnoses following COVID-19, including memory disorders, Parkinson's disease, and other neurodegenerative conditions, particularly in those with severe acute illness. Long COVID patients show elevated neurofilament light chain (NfL) levels — a biomarker of neuronal damage — and brain imaging changes in some studies.
What is APOE4 and how does it increase Alzheimer's risk?
APOE4 is the strongest common genetic risk factor for late-onset Alzheimer's disease, carried by ~14% of Europeans. APOE4 impairs amyloid-beta clearance (via impaired glymphatic clearance and LRP1 receptor binding), promotes neuroinflammation via microglial activation, and reduces synaptic repair. APOE4 carriers also appear to have worse cognitive outcomes following COVID-19.
What is GBA and why is it the key Parkinson's disease gene?
GBA (glucocerebrosidase) encodes a lysosomal enzyme mutated in Gaucher disease. Heterozygous GBA variants are the most common genetic risk factor for Parkinson's disease (~5–15% of PD patients carry GBA variants). GBA variants impair lysosomal function and promote alpha-synuclein accumulation in dopaminergic neurons. Homozygous pathogenic GBA variants cause Gaucher disease.
Which neurodegeneration genes are studied?
Key genes include APOE, TREM2, CLU, CR1, LRRK2, SNCA, GBA, PINK1, PRKN, TBK1, C9orf72, SOD1, and TARDBP. These cover amyloid clearance, microglial function, alpha-synuclein biology, mitophagy, and ALS/FTD-related mechanisms.
Explore DNA insights
If you already have DNA data from 23andMe, AncestryDNA, or MyHeritage, upload your raw file to ChronicDNA and receive a personalised educational report covering genes studied in relation to Neurodegeneration and connected biological pathways.
Get Your Personalised DNA ReportInformational and educational only · Not a diagnostic tool · GDPR compliant
6 genes · 10 variants analysed in relation to Neurodegeneration